Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose containing intravenous immunoglobulins. A case-control study

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 3, 2012, Pages 320-322

  Onuigbo, Macaulay A C ^a  

^a Mayo Clinic Health System   (United States)

Author keywords

Angiotensin blockade; IV Ig; Renal failure

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CONTRAST MEDIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; IMMUNOGLOBULIN; IODINATED CONTRAST MEDIUM; METHYLDOPA; NONSTEROID ANTIINFLAMMATORY AGENT; SUCROSE;

ACUTE KIDNEY FAILURE; ANTIHYPERTENSIVE THERAPY; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; CONTRAST INDUCED NEPHROPATHY; HEMODIALYSIS; HUMAN; NEPHROTOXICITY; NOTE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ACUTE KIDNEY INJURY; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; RENIN-ANGIOTENSIN SYSTEM; SUCROSE;

EID: 84858289678     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2273     Document Type: Note

References (15)

1. Chiang CW, Chen CY, Chiu HF, Wu HL, Yang CY. Trends in the use of antihypertensive drugs by outpatients with diabetes in Taiwan, 1997-2003. Pharmacoepidemiol Drug Saf 2007; 16(4): 412-21.
2. Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med 2007; 167(2): 141-7. Erratum in: Arch Intern Med 2007; 167(7): 648.
3. Scarsi KK, Bjornson DC. The use of ACE inhibitors as renoprotective agents in Medicaid patients with diabetes. Ann Pharmacother 2000; 34(9): 1002-1006.
4. Moulis G, Sailler L, Sommet A, Lapeyre-Mestre M, Montastruc J-L. Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose containing intravenous immunoglobulins. A case-control study. Pharmacoepidemiol Drug Saf 2012; 21(3): 314-319.
5. Onuigbo MA, Onuigbo NT. Late-onset renal failure from angiotensin blockade (LORFFAB) in 100 CKD patients. Int Urol Nephrol 2008; 40(1): 233-9. Epub 2008 Jan 15.
6. Onuigbo MA. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin nephrology practice. Hemodial Int 2009; 13(1): S24-9. PMID: 19775421. DOI: 10.1111/j.1542-4758.2009.00416.
7. Onuigbo MAC. Reno-prevention vs. reno-protection: a critical re-appraisal of the evidence-base from the large RAAS blockade trials after ONTARGET - a call for more circumspection. QJM 2009; 102: 155-167. [Epub ahead of print] Jan 5 2009.
8. Onuigbo MA. Can ACE Inhibitors and angiotensin receptor blockers be detrimental in CKD patients? Nephron Clin Pract 2011; 118(4): c407-c419. [Epub ahead of print].
9. Onuigbo MA, Onuigbo N. Chronic Kidney Disease and RAAS Blockade: A New View of Renoprotection. Lambert Academic Publishing GmbH & Co. KG: London, 2011. ISBN: 978-3-8454-1523-9.
10. Markowitz GS, Nasr SH, Klein P, et al. Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing. Hum Pathol 2004; 35(6): 675-84.
11. Pálmadóttir VK, Gudmundsson H, Hardarson S, Arnadóttir M, Magnússon T, Andrésdóttir MB. Incidence and outcome of acute phosphate nephropathy in Iceland. PLoS One 2010 Oct 19; 5(10): e13484.
12. Thakar CV, Kharat V, Blanck S, Leonard AC. Acute kidney injury after gastric bypass surgery. Clin J Am Soc Nephrol 2007 May; 2(3): 426-30. Epub 2007 Mar 14.
13. Arora P, Rajagopalam S, Ranjan R, et al. Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol 2008 Sep; 3(5): 1266-73. Epub 2008 Jul 30.
14. Kiski D, Stepper W, Brand E, Breithardt G, Reinecke H. Impact of renin-angiotensinaldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial. Nephrol Dial Transplant 2010 Mar; 25(3): 759-64. Epub 2009 Nov 9.
15. Komenda P, Zalunardo N, Burnett S, et al. Conservative outpatient renoprotective protocol in patients with low GFR undergoing contrast angiography: a case series. Clin Exp Nephrol 2007; 11(3): 209-13. Epub 2007 Sep 28.